| 12421233 |
WRN inhibitors |
Derun Li, Angela V. West, Justin Andrew Caravella, Nathan Genung, Florian Bartels +2 more |
2025-09-23 |
|
| 12344609 |
WRN inhibitors |
Derun Li, Angela V. West, Justin Andrew Caravella, Nathan Genung, Florian Bartels +2 more |
2025-07-01 |
|
| 12103921 |
Chemical compounds |
Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro Garcia, Ming Zhu Chen, Chulho Choi +10 more |
2024-10-01 |
$338,444,000 |
| 11702405 |
Chemical compounds |
Ariamala Gopalsamy, Shawn Cabral, Agustin Casimiro-Garcia, Ming Zhu Chen, Chulho Choi +10 more |
2023-07-18 |
$390,606,000 |
| 11673890 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2023-06-13 |
$591,478,000 |
| 11014908 |
Chemical compounds |
Ariamala Gopalsamy, Arjun Venkat Narayanan, Agustin Casimiro-Garcia, Chulho Choi, David Hepworth +10 more |
2021-05-25 |
$425,301,000 |
| 10822335 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2020-11-03 |
$385,583,000 |
| 10294225 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2019-05-21 |
$472,672,000 |
| 9908883 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2018-03-06 |
$304,169,000 |
| 9873673 |
2-thiopyrimidinones |
Philip A. Carpino, Edward L. Conn, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung +6 more |
2018-01-23 |
$117,720,000 |
| 9399626 |
2-thiopyrimidinones |
Philip A. Carpino, Edward L. Conn, Matthew S. Dowling, David Hepworth, Daniel Wei-Shung Kung +6 more |
2016-07-26 |
$447,864,000 |
| 9181252 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Scott W. Bagley, Aaron Smith |
2015-11-10 |
$341,611,000 |
| 9145416 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2015-09-29 |
$193,164,000 |
| 8993586 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Scott W. Bagley, Aaron Smith |
2015-03-31 |
$327,329,000 |
| 8859577 |
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors |
Mary Theresa Didiuk, David A. Griffith |
2014-10-14 |
$166,604,000 |
| 8859773 |
N1/N2-lactam acetyl-CoA carboxylase inhibitors |
David A. Griffith, Scott W. Bagley, Aaron Smith |
2014-10-14 |
$166,604,000 |
| 8802688 |
Substituted acetyl-coa carboxylase inhibitors |
David James Edmonds, David A. Griffith, James Alfred Southers, JR. |
2014-08-12 |
$289,501,000 |
| 7718645 |
Substituted bicyclolactam compounds |
Michael John Munchhof |
2010-05-18 |
$620,197,000 |
| 7713989 |
Glucocorticoid receptor modulators |
Kevin Liu, Bradley P. Morgan, Andrew G. Swick |
2010-05-11 |
|
| 7247628 |
Cannabinoid receptor ligands and uses thereof |
Marlys Hammond |
2007-07-24 |
$742,926,000 |
| 7241788 |
Cannabinoid receptor ligands and uses thereof |
Philip A. Carpino |
2007-07-10 |
$150,041,000 |
| 7230024 |
Cannabinoid receptor ligands and uses thereof |
Philip A. Carpino |
2007-06-12 |
$153,113,000 |
| 7166593 |
Glucocorticoid receptor modulators |
Kevin Liu, Bradley P. Morgan, Andrew G. Swick |
2007-01-23 |
$830,404,000 |
| 7151097 |
Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
Philip A. Carpino, David A. Griffith |
2006-12-19 |
$488,710,000 |
| 7145012 |
Cannabinoid receptor ligands and uses thereof |
Philip A. Carpino |
2006-12-05 |
$319,632,000 |
